Anxiety Disorders: Panic Disorder, OCD, PTSD – Pharmacological & Non-Pharmacological Interventions

Anxiety Disorders: Panic Disorder, OCD, PTSD – Pharmacological & Non-Pharmacological Interventions

A practical guide for clinicians, students, and caregivers.

What Is This?

Anxiety disorders—including Panic Disorder (PD), Obsessive-Compulsive Disorder (OCD), and Post-Traumatic Stress Disorder (PTSD)—are debilitating mental health conditions that impair daily functioning. This guide covers evidence-based pharmacological and non-pharmacological interventions to reduce symptoms, improve quality of life, and prevent relapse.

Why use this today? - Anxiety disorders affect 1 in 3 people in their lifetime. - First-line treatments (e.g., SSRIs, CBT) have 60–80% response rates but require precise application. - Misdiagnosis or improper treatment leads to chronic disability, substance abuse, or suicide risk.

Why It Matters

Real-World Impact

• Economic burden: Anxiety disorders cost the U.S. $42B/year in healthcare and lost productivity.
• Comorbidity: 50% of patients with depression also have an anxiety disorder; PTSD increases risk of cardiovascular disease.
• Treatment gaps: Only 37% of affected individuals receive adequate care due to stigma, access barriers, or clinician unfamiliarity.

Key Problems Solved

1. Acute symptom relief (e.g., panic attacks, flashbacks).
2. Long-term management (e.g., OCD rituals, avoidance behaviors).
3. Preventing relapse (e.g., tapering medications, maintenance therapy).

Core Concepts

1. Neurobiology of Anxiety Disorders

• Panic Disorder (PD): Dysregulation in the amygdala (fear center) and locus coeruleus (norepinephrine overactivity)-sudden, unprovoked panic attacks.
• OCD: Hyperactivity in the orbitofrontal cortex (OFC), anterior cingulate cortex (ACC), and basal ganglia-intrusive thoughts (obsessions) and repetitive behaviors (compulsions).
• PTSD: Hippocampal atrophy (memory dysfunction) + hyperactive amygdala-hypervigilance, flashbacks, and emotional numbness.

2. Treatment Modalities

3. First-Line vs. Second-Line Treatments

• First-line: SSRIs (e.g., sertraline, fluoxetine) + CBT (gold standard for all three disorders).
• Second-line: SNRIs (e.g., venlafaxine), TCAs (e.g., clomipramine for OCD), or MAOIs (rare, for treatment-resistant cases).
• Adjuncts: Benzodiazepines (short-term for PD), atypical antipsychotics (e.g., aripiprazole for OCD/PTSD), or prazosin (for PTSD nightmares).

4. Key Principles of Treatment

• Start low, go slow: Titrate medications to minimize side effects (e.g., SSRIs may initially worsen anxiety).
• Combine therapies: CBT + SSRIs > either alone for OCD/PTSD.
• Monitor for suicide risk: SSRIs may increase suicidal ideation in adolescents/young adults (black-box warning).
• Avoid benzodiazepines long-term: Risk of dependence, cognitive decline, and rebound anxiety.

How It Works

Pharmacological Interventions

1. SSRIs (Selective Serotonin Reuptake Inhibitors)

• Mechanism: Block serotonin reuptake-increased serotonin in synaptic cleft-downregulation of postsynaptic receptors over 4–6 weeks.
• Onset: 4–8 weeks for full effect (earlier for panic disorder).
• Examples:
• Panic Disorder: Sertraline, paroxetine.
• OCD: Fluoxetine, fluvoxamine (higher doses than for depression).
• PTSD: Sertraline, paroxetine (FDA-approved).

2. SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)

• Mechanism: Block serotonin + norepinephrine reuptake-useful for comorbid pain or fatigue (common in PTSD).
• Examples: Venlafaxine (PD, PTSD), duloxetine (PTSD with chronic pain).

3. Benzodiazepines (Short-Term Use Only)

• Mechanism: GABA-A receptor agonists-rapid anxiolysis (15–30 min).
• Use case: Acute panic attacks or bridging therapy while SSRIs take effect.
• Risks: Tolerance, dependence, withdrawal seizures.
• Example: Alprazolam (Xanax), clonazepam (Klonopin).

4. Atypical Antipsychotics (Adjunct for OCD/PTSD)

• Mechanism: Dopamine/serotonin antagonism-reduces intrusive thoughts/flashbacks.
• Examples: Aripiprazole, risperidone (low doses).

5. Prazosin (For PTSD Nightmares)

• Mechanism: Alpha-1 adrenergic blocker-reduces noradrenergic hyperactivity during sleep.
• Dose: Start at 1 mg at bedtime, titrate to 2–10 mg.

Non-Pharmacological Interventions

1. Cognitive Behavioral Therapy (CBT)

• Core components:
• Cognitive restructuring: Challenge catastrophic thoughts (e.g., "I’m having a heart attack"-"This is a panic attack; it will pass").
• Behavioral experiments: Test feared outcomes (e.g., "If I don’t wash my hands, I’ll get sick").
• Variants:
• Exposure and Response Prevention (ERP): Gold standard for OCD (e.g., touch a doorknob-resist handwashing).
• Prolonged Exposure (PE): For PTSD (e.g., recount trauma in safe setting).

2. Eye Movement Desensitization and Reprocessing (EMDR)

• Mechanism: Bilateral stimulation (eye movements, taps) while recalling trauma-reprocesses memories to reduce emotional charge.
• Use case: PTSD (especially single-event trauma).

3. Mindfulness-Based Stress Reduction (MBSR)

• Techniques: Body scans, meditation, yoga-reduces amygdala hyperactivity.
• Evidence: 30–40% reduction in anxiety symptoms (meta-analyses).

4. Lifestyle Modifications

Hands-On / Getting Started

Prerequisites

• Knowledge: Basic understanding of neurotransmitters (serotonin, GABA, norepinephrine) and CBT principles.
• Tools:
• For clinicians: DSM-5-TR, PHQ-9/GAD-7 (screening tools).
• For patients: Workbooks (e.g., "The Anxiety and Phobia Workbook" by Edmund Bourne).
• Apps: Woebot (CBT), PTSD Coach (VA), Headspace (mindfulness).

Step-by-Step: Treating Panic Disorder

1. Acute Panic Attack (First Aid)

• Do:
• Grounding technique (5-4-3-2-1):
  • Name 5 things you see, 4 you feel, 3 you hear, 2 you smell, 1 you taste.
• Slow breathing: Inhale 4 sec-hold 4 sec-exhale 6 sec.
• Avoid:
• Hyperventilating (use paper bag only if true hyperventilation is confirmed).
• Leaving the situation (reinforces avoidance).

2. Long-Term Management

• Medication:
• Start sertraline 25 mg/day-titrate to 50–200 mg/day over 4 weeks.
• Add clonazepam 0.25 mg PRN (max 2x/week) for breakthrough attacks.
• Therapy:
• CBT: 12–16 sessions focusing on interoceptive exposure (e.g., spinning in a chair to induce dizziness-learn it’s not dangerous).
• Lifestyle:
• Eliminate caffeine, exercise 3x/week, sleep 7–9 hours.

Expected Outcome

• Week 1–2: Reduced panic attack frequency (benzodiazepine effect).
• Week 4–6: SSRIs begin working; 50% reduction in attacks.
• Month 3–6: Remission (no attacks for 1+ month) with CBT.

Common Pitfalls & Mistakes

1. Overusing Benzodiazepines

• Mistake: Prescribing alprazolam 1 mg TID for chronic anxiety.
• Fix: Limit to <4 weeks, use lowest effective dose (e.g., clonazepam 0.25 mg PRN).

2. Under-Dosing SSRIs for OCD

• Mistake: Using fluoxetine 20 mg/day (standard for depression) for OCD.
• Fix: Fluoxetine 60–80 mg/day (OCD requires higher doses).

3. Avoiding Exposure Therapy in PTSD

• Mistake: Only using medications without trauma-focused therapy.
• Fix: Prolonged Exposure (PE) or EMDR is essential for PTSD.

4. Ignoring Comorbidities

• Mistake: Treating PTSD alone without addressing depression or substance use.
• Fix: Screen for depression (PHQ-9), alcohol use (AUDIT-C), and sleep disorders.

5. Stopping Medications Too Soon

• Mistake: Discontinuing SSRIs after 3 months of symptom relief.
• Fix: Minimum 12 months for PD/OCD, 2+ years for PTSD to prevent relapse.

Best Practices

For Clinicians

• Always combine meds + therapy: CBT + SSRIs > either alone.
• Use validated scales: Y-BOCS (OCD), PCL-5 (PTSD), PDSS (Panic Disorder).
• Monitor side effects:
• SSRIs: Sexual dysfunction (switch to bupropion), GI upset (take with food).
• Benzodiazepines: Sedation, memory impairment (avoid in elderly).
• Taper slowly: Reduce SSRIs by 25% every 2–4 weeks to avoid withdrawal.

For Patients

• Track symptoms: Use a mood journal (e.g., Daylio app).
• Gradual exposure: For OCD/PTSD, start with least feared triggers.
• Sleep hygiene: No screens 1 hour before bed, cool/dark room.
• Avoid alcohol: Worsens anxiety and interferes with SSRIs.

Tools & Frameworks

Pharmacological

Non-Pharmacological

Real-World Use Cases

1. Emergency Department: Acute Panic Attack

• Scenario: A 28-year-old woman presents with chest pain, palpitations, and fear of dying.
• Intervention:
• Rule out cardiac causes (ECG, troponin).
• Reassure: "This is a panic attack; it will pass in 10–30 minutes."
• Grounding: 5-4-3-2-1 technique.
• Discharge: Prescribe sertraline 25 mg/day + CBT referral.

2. Primary Care: Treatment-Resistant OCD

• Scenario: A 35-year-old man with contamination OCD (washes hands 50x/day) fails fluoxetine 40 mg/day.
• Intervention:
• Increase fluoxetine to 80 mg/day.
• Add aripiprazole 2 mg/day (adjunct).
• Refer to ERP specialist (e.g., "Touch a doorknob-delay handwashing for 5 minutes").

3. VA Clinic: PTSD with Nightmares

• Scenario: A 42-year-old veteran with PTSD (combat-related) has daily nightmares and avoids crowds.
• Intervention:
• Prazosin 2 mg at bedtime (titrate to 6 mg).
• Prolonged Exposure (PE) therapy (12 sessions).
• Group therapy (veteran support groups).

Check Your Understanding (MCQs)

Question 1

A 25-year-old woman with panic disorder has been taking sertraline 50 mg/day for 6 weeks but still has 2–3 panic attacks per week. What is the next best step?

A) Increase sertraline to 100 mg/day. B) Add alprazolam 0.5 mg TID. C) Switch to venlafaxine 75 mg/day. D) Refer for interoceptive exposure therapy.

Correct Answer: A Explanation: SSRIs for panic disorder often require higher doses (e.g., sertraline 100–200 mg/day). Interoceptive exposure (D) is also appropriate but should be combined with medication optimization. Why the Distractors Are Tempting: - B) Benzodiazepines work quickly but should not be used long-term. - C) Venlafaxine is a second-line option, but maximizing